Scholarlink

<p>EndoBridge 2024 was held from October 18–20, 2024, in Antalya, Türkiye. The scientific program of the 12th Annual Meeting of EndoBridge, accredited by the European Council, featured advanced lectures and interactive case discussion sessions in small groups, all delivered by internationally renowned experts in the field. The event attracted a wide range of attendees and offered an extensive overview of key topics in endocrinology and metabolism. These included pituitary, thyroid, bone, and adrenal diseases, neuroendocrine tumors, diabetes, obesity, nutrition, and lipid disorders. Abstracts of clinical cases presented during oral and poster sessions were published in <i>JCEM Case Reports</i>. This article summarizes the major highlights and key insights from the meeting, covering a broad spectrum of topics such as management of acromegaly, treatment of subclinical thyroid disease, goal-directed treatment for osteoporosis, the role of adjunctive therapies in type 1 diabetes mellitus, phenotyping obesities, hormonal management of menopause and premature ovarian failure, and updates on male hypogonadism and infertility. These discussions present the most recent advancements in endocrinology and offer clinical perspectives on prevalent endocrine conditions. The 13th Annual EndoBridge Meeting is scheduled to be held from October 23 to 26, 2025, in Antalya, Türkiye.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

EndoBridge 2024: pearls and highlights

  • 期刊论文

  • 发表日期：

    2025年8月6日

查看全文
  • Bulent Okan Yildiz,
  • Eleni Armeni,
  • Chrysanthi Balodimou,
  • Bernadette Biondi,
  • Andreea Ciudin,
  • Gema Frühbeck,
  • Ghada El-Hajj Fuleihan,
  • Eliza B. Geer,
  • Pieter Gillard,
  • Catherine M. Gordon,
  • Dimitrios Goulis,
  • Gary D. Hammer,
  • Charlotte Höybye,
  • Bente Lomholt Langdahl,
  • Alexandra B. Laufer,
  • AJ van der Lely,
  • Djuro Macut,
  • Julia K. Mader,
  • Barbara McGowan,
  • Eva Novac,
  • Duarte Pignatelli,
  • Misa Pfeifer,
  • Lena Radić,
  • Viral Shah,
  • Constantine A. Stratakis,
  • Gerlies Treiber,
  • Dionysios N. Vrachnis,
  • John Wilding,
  • Dilek Yazici,
  • Ozlem Celik

摘要

EndoBridge 2024 was held from October 18–20, 2024, in Antalya, Türkiye. The scientific program of the 12th Annual Meeting of EndoBridge, accredited by the European Council, featured advanced lectures and interactive case discussion sessions in small groups, all delivered by internationally renowned experts in the field. The event attracted a wide range of attendees and offered an extensive overview of key topics in endocrinology and metabolism. These included pituitary, thyroid, bone, and adrenal diseases, neuroendocrine tumors, diabetes, obesity, nutrition, and lipid disorders. Abstracts of clinical cases presented during oral and poster sessions were published in JCEM Case Reports. This article summarizes the major highlights and key insights from the meeting, covering a broad spectrum of topics such as management of acromegaly, treatment of subclinical thyroid disease, goal-directed treatment for osteoporosis, the role of adjunctive therapies in type 1 diabetes mellitus, phenotyping obesities, hormonal management of menopause and premature ovarian failure, and updates on male hypogonadism and infertility. These discussions present the most recent advancements in endocrinology and offer clinical perspectives on prevalent endocrine conditions. The 13th Annual EndoBridge Meeting is scheduled to be held from October 23 to 26, 2025, in Antalya, Türkiye.